LACK OF SIGNIFICANT IMPACT ON HOSPITALIZATION DUE TO RSV INFECTION BY PALIVIZUMAB PROPHYLAXIS AMONG CHILDREN WITH HEART DISEASE IN CALIFORNIA.

  • Chang, Ruey-Kang MD, MPH

  • 1Pediatrics, Harbor-UCLA Medical Center, Torrance, CA.

Congenital Heart Disease 3(5):p 393, September-October 2008.
Copyright © 2008 Blackwell Publishing Ltd.